UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________ Form 10-Q ________________________________________________________________________________ ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commissi ...

LifeVantage Corporation (NASDAQ:LFVN) Q1 2024 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President & Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Doug Lane - Water Tower Research Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's First Quarter of Fiscal 2024 Results. [Operator Instructions] Hosting today's conference will be ...

Financial Performance - For the three months ended September 30, 2023, net revenue was $51,364,000, a decrease of 0.8% compared to $51,774,000 for the same period in 2022[17] - Gross profit for the quarter was $41,184,000, down from $41,832,000 year-over-year, reflecting a gross margin of approximately 80.1%[17] - Operating income decreased to $749,000 from $1,290,000 in the prior year, indicating a decline of 42%[17] - Net income for the quarter was $629,000, slightly up from $610,000 in the same quarter last year, resulting in a net income per share of $0.05[17] - The company reported a comprehensive income of $335,000 for the quarter, compared to $100,000 in the same period last year[17] - Net income for the three months ended September 30, 2023, was $629,000, an increase from $610,000 in the same period of 2022, representing a growth of approximately 3.1%[24] Assets and Liabilities - Total current assets decreased to $41,901,000 as of September 30, 2023, down from $44,284,000 at the end of the previous quarter[15] - Total liabilities increased to $37,310,000 from $31,474,000, primarily due to an increase in accounts payable and current liabilities[15] - Cash and cash equivalents decreased to $18,405,000 from $21,605,000, indicating a cash reduction of approximately 14%[15] - The accumulated deficit increased to $104,005,000 as of September 30, 2023, from $98,305,000 at the end of the previous quarter[15] - Total inventory as of September 30, 2023, was $15,706,000, a decrease from $16,073,000 as of June 30, 2023, indicating a reduction of approximately 2.3%[38] Cash Flow and Dividends - Cash flows from operating activities provided $4,765,000 in Q3 2023, a significant improvement compared to a cash outflow of $1,345,000 in Q3 2022[24] - The company paid $5,534,000 in cash dividends during the three months ended September 30, 2023, compared to $377,000 in the same period of 2022[24] - Cash and cash equivalents at the end of the period were $18,405,000, compared to $17,619,000 at the end of the same period in 2022, showing an increase of approximately 4.5%[24] - The board of directors declared a quarterly cash dividend of $0.035 per share and a one-time cash dividend of $0.40 per share, totaling $5.5 million for the three months ended September 30, 2023[79] - Cash dividends for the same period in 2022 totaled $0.4 million, or $0.03 per share, indicating a significant increase in dividend payouts year-over-year[80] Research and Development - Research and development expenses for the three months ended September 30, 2023, were $200,000, up from $100,000 in the same period of 2022, reflecting a 100% increase[46] Stock and Shareholder Information - The Company issued 0.3 million shares of common stock under equity award plans during the three months ended September 30, 2023, compared to 48,000 shares in the same period of 2022[73] - The Company has a remaining balance of $26.1 million under its share repurchase program as of September 30, 2023, having purchased 0.1 million shares at an aggregate price of $0.8 million during the three months ended September 30, 2023[74] - Stock-based compensation for the three months ended September 30, 2023, was $1.0 million, compared to $0.6 million for the same period in 2022, reflecting a 66.67% increase[88] - Approximately 39,000 shares of common stock were issued under the Employee Stock Purchase Plan (ESPP) during the three months ended September 30, 2023, compared to 36,000 shares in the same period of 2022[87] - The company has reserved 0.4 million shares of its common stock for issuance under the ESPP, with 0.1 million shares available as of September 30, 2023[84] Market and Operational Challenges - The company anticipates ongoing challenges in managing independent consultants and expanding into new international markets, which may impact future performance[10] - The company closed its e-commerce business in China on March 15, 2023, impacting its market presence in that region[28] Other Financial Information - The effective interest rate on the Company's 2016 Credit Facility was 8.55% as of September 30, 2023, with no balance outstanding on the facility at that date[72] - The Company recognized income tax expense of $0.2 million for both the three months ended September 30, 2023, and 2022, reflecting its current estimated effective tax rate[54] - The Company has no remaining lease liability for the abandoned showrooms in Hong Kong and Singapore, which were terminated in February 2023[49] - The weighted average remaining lease term for operating leases was 7.78 years as of September 30, 2023, down from 8.27 years as of June 30, 2023[61] - The Rights Plan is set to expire on August 24, 2024, unless terminated earlier, and aims to protect the interests of the company and its stockholders[77] - As of September 30, 2023, no preferred stock has been issued, and no rights or preferences have been assigned to preferred stock by the board of directors[78] - The company assessed potential contingent liabilities and found no probable loss contingencies requiring accrual or disclosures as of September 30, 2023[89] - There were no substantial changes to market risks during the quarter ended September 30, 2023, compared to the previous disclosures[138]

LifeVantage Corporation (NASDAQ:LFVN) Q4 2023 Earnings Conference Call August 28, 2023 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President and CEO Carl Aure - CFO Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's Fourth Quarter and Full Fiscal Year 2023 Results. [Operator Instructions] I would like to inform you that LifeVantage intends to file a proxy statement and related proxy ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from __________ to __________ Commission file number: 001-35647 ________________________________________ ...

LifeVantage Corporation (NASDAQ:LFVN) Q3 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Reed Anderson - ICR Steve Fife - President and Chief Executive Officer Carl Aure - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's conference call to discuss LifeVantage's Third Quarter Fiscal 2023 Results. [Operator Instructions] Hosting today's conference will be Reed Anderson with ICR. As a reminder, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________ Form 10-Q ________________________________________________________________________________ ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission ...

LifeVantage Corporation (NASDAQ:LFVN) Q2 2023 Earnings Conference Call February 2, 2023 4:30 PM ET Company Participants Reed Anderson - Investor Relations Steve Fife - President and Chief Executive Officer Carl Aure - Chief Financial Officer Operator Good day, ladies and gentlemen. Thank you for standing by. Welcome to today’s Conference Call to discuss LifeVantage’s Second Quarter Fiscal 2023 Results. [Operator Instructions] Hosting today’s conference will be Reed Anderson with ICR. As a reminder, today’s ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________ Form 10-Q ________________________________________________________________________________ ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commissi ...

Financial Performance - Net revenue for the three months ended September 30, 2022, was $51.774 million, a decrease of 2.6% compared to $53.224 million for the same period in 2021[17]. - Gross profit for the same period was $41.832 million, down from $43.793 million, reflecting a gross margin of approximately 80.7%[17]. - Operating income decreased to $1.290 million from $4.612 million, indicating a significant decline in operational performance[17]. - Net income for the quarter was $610,000, a decrease of 81.7% compared to $3.316 million in the prior year[17]. - Total revenue for the three months ended September 30, 2022, was $51.77 million, down 2.7% from $53.22 million in the same period of 2021[62]. - Revenue from the Americas region was $36.37 million, slightly down from $36.45 million in 2021, while revenue from the Asia/Pacific & Europe region decreased to $15.41 million from $16.78 million[62]. - Basic and diluted income per share for the three months ended September 30, 2022, was $0.05, compared to $0.25 in the same period of 2021[60]. Assets and Liabilities - Total current assets as of September 30, 2022, were $42.923 million, down from $46.957 million as of June 30, 2022[16]. - Total liabilities decreased to $35.710 million from $39.190 million, indicating improved financial leverage[16]. - Cash and cash equivalents decreased to $17.619 million from $20.190 million, reflecting a cash outflow during the quarter[16]. - Total stockholders' equity increased to $31.890 million from $31.516 million, showing a slight improvement in the company's net worth[16]. - Cash and cash equivalents at the end of the period were $17,619,000, a decrease of 11.6% from $19,929,000 at the end of Q3 2021[25]. - The company had $12.2 million in cash accounts at one financial institution as of September 30, 2022[39]. Cash Flow and Expenses - Cash flows from operating activities resulted in a net cash used of $1,345,000 for Q3 2022, compared to a net cash provided of $465,000 in Q3 2021[25]. - The company’s cash paid for income taxes was $439,000 for the three months ended September 30, 2022, compared to $468,000 in the same period of 2021[25]. - Operating lease expense for the three months ended September 30, 2022, was $0.7 million, a decrease from $0.8 million in the same period of 2021[67]. - Research and development expenses for the three months ended September 30, 2022, were $100,000, down from $200,000 in the same period of 2021[48]. Inventory - Total inventory as of September 30, 2022, was $18,636,000, an increase of 13.1% from $16,472,000 as of June 30, 2022[41]. - The company’s inventory included $14,571,000 in finished goods, representing 78.2% of total inventory as of September 30, 2022[41]. Legal and Regulatory Matters - The company is involved in a class action lawsuit alleging operation of a pyramid scheme, with the case currently in the Federal District Court for Utah[95]. - The court dismissed three of the plaintiff's four claims, including antitrust and unjust enrichment claims, but allowed a securities fraud claim to proceed[95]. - The plaintiffs filed a second amended complaint including a 10(b)(5) securities fraud claim, which the company responded to on December 23, 2020[95]. - The court denied the plaintiff's motion for class certification on April 19, 2022, and the case has been stayed until November 25, 2022[95]. - The company has not established a loss contingency accrual for the lawsuit, believing liability is not probable or estimable[95]. - The company may face other litigation and regulatory matters, including product liability claims and commercial disputes, but does not expect these to materially affect its business[96]. Future Outlook - The company anticipates ongoing challenges related to market expansion and product acceptance, which may impact future performance[11]. Shareholder Actions - During the three months ended September 30, 2022, the Company declared a quarterly cash dividend of $0.03 per share, totaling $0.4 million[82]. - The Company has a remaining authorization of $27.7 million under its share repurchase program as of September 30, 2022[80]. - For the three months ended September 30, 2022, the Company issued approximately 36,000 shares under the Employee Stock Purchase Plan (ESPP)[90]. - The Company reported stock-based compensation of $0.6 million for both the three months ended September 30, 2022 and 2021[91]. - As of September 30, 2022, there were stock option awards outstanding for an aggregate of approximately 14,000 shares under the 2010 Long-Term Incentive Plan[85]. - The maximum number of shares available for issuance under the 2017 Long-Term Incentive Plan is 2.9 million as of September 30, 2022[86]. - The Company has reserved 0.4 million shares of its common stock for issuance under the ESPP, with 0.2 million shares available as of September 30, 2022[88]. - The Company has not issued any preferred stock as of September 30, 2022[81]. Market Risks - There were no substantial changes to market risks during the quarter ended September 30, 2022, compared to the previous annual report[146].